Agenda

Start

End

Pre-Conference -  November 30, 2023 

Speaker(s)

Understanding and Applying the Latest Advances for Managing Diabetic Foot Complications: A Hands-On Workshop

Diabetes foot complications are debilitating and costly, with morbidity and mortality rates at higher levels than many cancers.  Nonetheless, research developments into prevention and management are making great strides.  This hands-on workshop will discuss how innovative approaches and smart technologies may optimize the management and prevention of diabetic foot complications with timely identifying high-risk patients in need of interventions and improving adherence to treatment protocols.

This activity is supported by an educational grant from Defender Ops/Next Science, LifeNet Health, MiMedx, MTF Biologics, Organogenesis Inc., Orpyx^®and Smith & Nephew, Inc.

TBA

Start

End

Day 1 -  December 1, 2023

Speaker(s)

Remote Patient Monitoring

Change in healthcare is being accelerated by the fast-aging world population with increasing health complications.   Remote patient monitoring (RPM) has emerged as a significant tool in disease prevention with a wide range of devices designed to monitor physiologic indicators of clinical interest for a variety of health conditions, especially diabetes related complications.  This session will examine advancements and what the future holds for RPM.

Virtual Keynote: Lawrence B. Harkless Leadership in the Diabetic Foot Award:
 Lessons from Paul W. Brand – Progress in the Last 40 Years

This year’s keynote address reflects in the progress made in caring for the diabetic foot.  The legacy left by Dr. Paul W. Brand and, most currently, Dr. Lawrence B. Harkless have been major influences in the evolvement of Diabetic Foot diagnosis and treatment as well as in the personal and professional live of the keynote speaker, Dr. Andrew J.M. Boulton. 

Andrew J.M. Boulton, MD, DSc (Hon), FACP, FICP, FRCP

Industry Supported Symposium
Supported by an educational grant from Kerecis.

Fireside Chat: Multidisciplinary Management of PAD 

Peripheral arterial disease (PAD) and its multiorgan effect is complex and requires collaboration of a multispecialty team.  A team approach has been proven to significantly improve patient outcomes and decreasing amputation rates.  In a relaxed setting, where the audience will have the opportunity to participate in the discussion, this session will provide multidisciplinary perspectives to manage PAD. 

Industry Supported Symposium 
Supported by an educational grant from Medtronic.

Fireside Chat: When to Perform Foot Surgery After Revascularization?

There is a widespread belief that it is necessary for revascularization to be undertaken before surgical debridement, with a goal to maximize the possibility of rapid and definitive wound healing. Comparably, because time is of vital importance in preserving ischemic tissue, many clinicians believe that a successful intervention should occur immediately before surgery.  This session will be an informal yet structured conversation between the presenters and audience on the optimal waiting period for foot salvage surgery following limb revascularization.

Ammar Hashmi, MD
Melissa Kirkwood, MD
Michael Siah, MD
Matthew Sideman, MD

Glycemic Control and Diabetic Foot Surgery: Does It Predict Outcomes?

The two sides of this debate argue if there is an association between glycemic control (hemoglobin A1C, fasting glucose, and random glucose) and the outcomes of wound healing and lower extremity amputation (LEA).  Will the presenters provide compelling evidence to support their positions or will further studies be needed to achieve a final conclusion?

Discussion: Family Feud - Bridging the Generations in Diabetic Foot Treatments

Inspired by the popular gameshow, Family Feud, this session will feature two families representing two generations of podiatry- who will compete to get the most questions on diabetic foot complications answered. 

Alexandria Armstrong, DPM
David Armstrong, DPM, MD, PhD

Start

End

Day 2 - December 2, 2023

Speaker(s)

Debate: Nutritional Intervention Improves Wound Healing: Evidence or Personal Opinion?

How important is to evaluate and address the appropriate nutritional care of patients with wounds?  The disputants will share their “for” or “against” views on the role of nutrition in wound healing.  The audience will evaluate decide who makes the stronger argument.

Peter Andrew Crisologo, DPM, FFPM RCPS (Glasg)
vs.
Alicia Gilmore, MS, RD, CSO, LD

Patient-Centric Advancements for Painful and Non-Painful Diabetic Neuropathy 

Fast symptom identification and aggressive glycemic control is critical in controlling the development of neuropathic complications; however, adequate pain relief remains challenging and an area of debate. Pharmacotherapy with anticonvulsants and antidepressants are common first-line agents. There is an emerging role for neuromodulation treatment modalities including intrathecal drug delivery and spinal cord stimulation, as well as topical analgesics.  Improving pain outcomes requires an individualized patient approach.  This session will consider pharmacotherapy, surgical treatments including neuromodulation, (capsaicin) 8% patch, and other holistic alternative therapies to improve pain management outcomes.

Learning Objectives:

• Review the prevalence and impact of painful diabetic neuropathy
• Review the landscape of technologies for management of painful and non-painful diabetic neuropathy
• Assess the clinical evidence for the use of capsaicin 8% patch application for pain relief and restoration of function via nerve fiber regeneration
• Correlate the loss of sensory nerve fibers or their protective function as major contributors to the development, recurrence, or non-healing of diabetic foot ulcers

This activity is supported by an educational grant from Averitas.

Michael King, DPM, FACFAS
Jason C. Snyder, DPM

Debate: Diabetic Foot Infection -
Systemic Treatment vs. Surgical Resection 

Arguments for the approach to treating diabetic foot infections are presented in this session, including selecting appropriate empiric and definitive antimicrobial therapy for soft tissue and for bone infections or when and how to approach surgical treatment.  This session will debate which therapies are most useful for the infectious aspects of diabetic foot complications. 

Discussion: Complex Case Theater

This session will explore illustrative complex cases navigated by a panel of experts, generating stimulating discussions that explore a variety of treatment approaches in an effort to optimize patient outcomes.